Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Intangibles (2016 - 2025)

Sanofi's Intangibles history spans 5 years, with the latest figure at $22.1 billion for Q4 2022.

  • For Q4 2022, Intangibles fell 9.84% year-over-year to $22.1 billion; the TTM value through Dec 2022 reached $22.1 billion, down 9.84%, while the annual FY2022 figure was $22.8 billion, 9.97% down from the prior year.
  • Intangibles for Q4 2022 was $22.1 billion at Sanofi, down from $24.5 billion in the prior quarter.
  • Across five years, Intangibles topped out at $25.0 billion in Q4 2018 and bottomed at $87.2 million in Q3 2018.
  • The 3-year median for Intangibles is $23.3 billion (2022), against an average of $17.9 billion.
  • The largest annual shift saw Intangibles skyrocketed 62.23% in 2018 before it decreased 9.84% in 2022.
  • A 3-year view of Intangibles shows it stood at $25.0 billion in 2018, then dropped by 1.98% to $24.5 billion in 2021, then dropped by 9.84% to $22.1 billion in 2022.
  • Per Business Quant, the three most recent readings for SNY's Intangibles are $22.1 billion (Q4 2022), $24.5 billion (Q4 2021), and $25.0 billion (Q4 2018).